Follow
Buthina A. Al-Oudat
Buthina A. Al-Oudat
Associate professor in Medicinal Chemistry, Jordan University of Science and Technology
Verified email at just.edu.jo
Title
Cited by
Cited by
Year
Generation of the first structure-based pharmacophore model containing a selective “zinc binding group” feature to identify potential glyoxalase-1 inhibitors
Q Al-Balas, M Hassan, B Al-Oudat, H Alzoubi, N Mhaidat, A Almaaytah
Molecules 17 (12), 13740-13758, 2012
402012
Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators
BA Al-Oudat, MA Alqudah, SA Audat, QA Al-Balas, T El-Elimat, ...
Drug Design, Development and Therapy 2019 (13), 423—433, 2019
232019
Synthesis of C3′ modified nucleosides for selective generation of the C3′-Deoxy-3′-thymidinyl radical: A proposed intermediate in LEE induced DNA damage
SAS Audat, CA Trzasko Love, BAS Al-Oudat, AC Bryant-Friedrich
The Journal of organic chemistry 77 (8), 3829-3837, 2012
112012
Novel Chrysin-De-Allyl PAC-1 Hybrid Analogues as Anticancer Compounds: Design, Synthesis, and Biological Evaluation
BA Al-Oudat, H Ramapuram, S Malla, SA Audat, N Hussein, JM Len, ...
Molecules 25 (13), 3063, 2020
102020
Design, synthesis and biological evaluation of novel glyoxalase I inhibitors possessing diazenylbenzenesulfonamide moiety as potential anticancer agents
BA Al-Oudat, MJ Hana'a, QA Al‑Balas, NA Al-Shar'i, A Bryant-Friedrich, ...
Bioorganic & Medicinal Chemistry 28 (16), 115608, 2020
92020
3′-Modified oligodeoxyribonucleotides for the study of 2-deoxyribose damage in DNA
B Al-Oudat, A Salyer, K Trabbic, A Bryant-Friedrich
Bioorganic & medicinal chemistry letters 23 (3), 854-859, 2013
72013
Design, synthesis, and biological evaluation of SMYD3 inhibitors possessing N-thiazole benzenesulfonamide moiety as potential anti-cancer agents
SA Audat, NA Al-Shar'i, BA Al-Oudat, S Alnabulsi
Journal of Saudi Chemical Society 26 (3), 101482, 2022
42022
Design, Synthesis and Biological Evaluation of 1, 4-Benzenesulfonamide Derivatives as Glyoxalase I Inhibitors
SA Audat, QA Al-Balas, BA Al-Oudat, MJ Athamneh, A Bryant-Friedrich
Drug Design, Development and Therapy, 873-885, 2023
32023
Identification of human leukotriene A4 hydrolase inhibitors using structure-based pharmacophore modeling and molecular docking
SA Audat, NA Al-Shar’i, BA Al-Oudat, A Bryant-Friedrich, MF Bedi, ...
Molecules 25 (12), 2871, 2020
22020
Lead optimization and biological evaluation of diazenylbenzenesulfonamides inhibitors against glyoxalase-I enzyme as potential anticancer agents
BA Al-Oudat, NA Al-Shar'i, QA Al‑Balas, SA Audat, MAY Alqudah, ...
Bioorganic Chemistry 120, 105657, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–10